Cleared Traditional

K090886 - RTX 3371

K090886 is an FDA 510(k) clearance for RTX 3371, manufactured by Tunstall Healthcare. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 15-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
15d
Days
Class 2
Risk

K090886 is an FDA 510(k) clearance for the RTX 3371. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Tunstall Healthcare (Noerresundby, NO). The FDA issued a Cleared decision on April 15, 2009 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tunstall Healthcare devices

FDA 510(k) Submission Details - K090886

510(k) Number K090886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2009
Decision Date April 15, 2009
Days to Decision 15 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 125d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Dekra Certification B.V
HARRY VAN VUGT

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 178
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K090886.
CARE PAL, MODEL CPW-10X
K091430 · Digio2 International Co., Ltd. · Aug 2009
MODIFICATION TO MEDICOMPASS CONNECT
K091021 · Imetrikus, Inc. · Jul 2009
MEDAPPS 2.0 REMOTE PATIENT MONITORING SYSTEM
K083862 · Medapps, Inc. · Jun 2009
ELECTRONIC HOUSE CALL
K090801 · Express MD Solutions, LLC · Apr 2009
HOSPIRA VITAL SIGNS WIRELESS MONITORING SYSTEM
K090610 · Hospira, Inc. · Mar 2009
HEALTH MANAGER, VERSION 1.1
K081499 · Biocomfort Diagnostics GmbH & Co. KG · Jan 2009